Results 161 to 170 of about 81,015 (310)
Unusual Etiology of Budd‐Chiari Syndrome in an Adolescent: A Case of Combined Thrombophilic Disorder
ABSTRACT Budd‐Chiari syndrome (BCS) is an uncommon but potentially life‐threatening hepatic vascular disorder resulting from obstruction of the hepatic venous outflow. While it predominantly affects adults, pediatric and adolescent presentations are rare, particularly those associated with inherited thrombophilia.
Santosh Sah +5 more
wiley +1 more source
The Practice of Interventional Gastrointestinal Endoscopy at a Tertiary Referral Hospital
Background: Interventional endoscopy enables one time diagnosis and treatment of gastrointestinal diseases with minimally invasive therapy and improved disease outcome. Local use has remained low with minimal reporting. Knowledge of current practice at a
James Waweru +5 more
doaj
Pediatric liver transplantation. Part II. Diagnostic imaging in postoperative management [PDF]
Bron, KM +6 more
core +1 more source
ROTEM showed a strong correlation with conventional coagulation tests (CCTs) but failed to assess re‐balanced hemostasis. Similar to ROTEM, using higher CCT thresholds may help reduce unnecessary plasma transfusions before invasive procedures. ABSTRACT Background Periprocedural rotational thromboelastometry (ROTEM) could reduce transfusions while ...
Nuanrat Cheerasiri +3 more
wiley +1 more source
Endoscopic Histoacryl injection with clips is associated with lower early rebleeding compared to Histoacryl injection alone in the treatment of gastric varices. [PDF]
Wei Y, Huang S, Zhu C, Huang J.
europepmc +1 more source
Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969–2002 [PDF]
Knut Stokkeland +3 more
openalex +1 more source
Comparative Study of Esophageal Varices Grading by Multi-Detector Computed Tomography and Endoscopy [PDF]
M.D. MOHAMED M. MABROUK FATMA A. EL-SHARAWY
openalex +1 more source
ABSTRACT The oral cholate challenge test of liver health, intended for use in compensated advanced chronic liver disease, was launched through an Early Access Program (EAP) in 2023–2024. Tests were provided to 16 clinicians at five liver centres across the US. The tested patients (n = 129) represented a range of etiologies and stages of disease.
Stuart C. Gordon +3 more
wiley +1 more source

